Mitsubishi Tanabe Pharma Corp.

Pharmaceuticals
Japan
Earnings Per Share Growth (%)N/A
Cost of Goods Sold (US$ Millions)$1,294
Current Liabilities (US$ Millions)$759
Total Assets (US$ Millions)$5,460
Long Term Debt$6
Return on Equity7.15%
Revenue (US$ Millions)$3,586
Total Company Assets$7,728
Revenue Growth (%)4.00%
Net Income (US$ Millions)$469
Earnings Per Share (US$)N/A
Total Equity (US$ Millions)$6,695
Profit Margin (%)13.07%
Debt To Equity Ratio (%)0.00%
Inventory Turnover$628